immunocal glutathione in cancer cells Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of lung by reprograming the tumor microenvironment Glutathione responsive nanomedicine leverages tumor
Description
Combined cyclophosphamide, fludarabine, alemtuzumab, and rituximab (CFAR), an active regimen for heavily treated patients with CLL
Entwickelt werden die Produkte vom Firmengrnder Dr
ChaC2, an enzyme for slow turnover of cytosolic glutathione
The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
